Draft medication scaffold. Needs source pass before publish.
Sections
Imipramine is one of the old tricyclics, which means it comes from that era when antidepressants were often effective and often annoying in equal measure, and if we’re being honest that’s still basically the sales pitch now… Tofranil works, that part is real, but the reason people don’t reach for it first very often anymore is also pretty obvious, because the side effects, overdose risk, and general burden are harder to justify now that we’ve got cleaner options for most of the same jobs.
That doesn’t make imipramine obsolete. It just makes it more selective, more deliberate, more of an old-school medication you use because you mean it and not because you forgot newer psychiatry happened. There are still situations where a stronger, messier antidepressant is worth the trouble, especially in panic disorder and some resistant or niche cases, but I wouldn’t call this drug elegant and I don’t think pretending otherwise helps anybody.
What it actually does
Imipramine is a tricyclic antidepressant that increases norepinephrine and serotonin signaling. In plain language, it’s a broad older antidepressant with a lot of receptor spillover, which is why it can help mood and anxiety and also cause dry mouth, constipation, sedation, dizziness, sweating, sexual side effects, and heart-conduction concerns, all at the same time if the day is going badly enough.
That receptor mess is both the power and the problem… the drug has real antidepressant and antipanic efficacy, and in some patients you can feel that very directly, but it also feels more burdensome than newer agents for a lot of people, and in overdose it’s much less forgiving than SSRIs.
Where it tends to help most
Panic disorder is one of the clearest places imipramine still has an honest clinical story. Controlled trials showed real benefit, and this is one of the older drugs that helped establish that panic could be treated pharmacologically instead of just moralized about or written off as temperament.
When it makes sense and when it doesn’t
I like imipramine when panic disorder is stubborn, when someone has reason to try an older proven agent, or when previous treatment history gives a concrete reason to think this drug may be worth the burden. Sometimes it’s the right old hammer and I don’t think modernity alone is a reason to pretend otherwise.
I don’t love it as a casual first move in modern outpatient psychiatry, in patients with significant suicide risk, in people who are already struggling with constipation, urinary retention, dizziness, or cardiac issues, or in anyone who’s likely to hate a medication with this much side-effect personality.
- What symptom or function is supposed to change, not just whether the medication feels noticeable.
- Sleep, appetite, libido, mood, anxiety, blood pressure, sedation, and any side effect that changes the trade.
- Missed doses, alcohol, cannabis, and other meds, because those can make a clean read impossible.
The useful question with Imipramine (Tofranil) is not whether it sounds strong or old or scary. The useful question is whether the benefit is real enough to justify the trade.
The patient-autonomy part
If somebody hears the trade and says they still want to try it because the newer options have failed or because panic has been brutal enough that they’re willing to tolerate more, that’s a completely reasonable adult decision. Harder-to-tolerate doesn’t mean wrong.
If they hear the same trade and decide they want cleaner options first, that’s reasonable too. Patients don’t owe old medications a nostalgia discount just because they worked for previous generations.
What to know before stopping or switching
Don’t stop imipramine abruptly after regular use if you can help it. Tricyclic discontinuation can bring rebound symptoms and a rough physical letdown, so tapering is usually the saner move, and I think with drugs like this the exit plan deserves almost as much respect as the entry plan.
If you’re switching because the side effects are too heavy, that’s not weakness and it’s not unusual. A drug can be effective and still be the wrong fit because the burden is too high.
Bottom line
Imipramine is an old tricyclic that still has real efficacy, especially in panic disorder and depression, but it asks more from patients than most newer options do. Its advantage is that it works. Its downside is that it works with a lot of baggage and a narrower safety margin. That makes it a selective tool now, not an extinct one.
Sources
- DailyMed. TOFRANIL imipramine hydrochloride tablet, sugar coated. National Library of Medicine. Accessed June 6, 2026. Official label.
- Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA. 2000;283(19):2529-2536. PMID 10815116.
- Mavissakalian MR, Perel JM. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships. Am J Psychiatry. 1995;152(5):673-682. PMID 7726306.
- Elliott AJ, Uldall KK, Bergam K, et al. Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients. Am J Psychiatry. 1998;155(3):367-372. PMID 9501747.
